The Role of Artificial Intelligence in Heart Failure Management
In a recent commentary, Dr. Michelle Kittleson, a heart failure transplant cardiologist, highlights the transformative potential of artificial intelligence (AI) in heart failure (HF) management. AI, particularly through machine learning, enables advanced pattern recognition and data-driven decision-making. It shows promise in early detection, such as predicting incident HF using electronic health records, which could prompt timely interventions like echocardiograms or peptide assessments.
Exploring the Obesity Paradox and Breakthrough Treatments in Heart Failure
Dr. Javed Butler and Dr. Mikhail Kosiborod explore the “obesity paradox” in heart failure (HF), where higher body mass index in patients with HF, particularly with reduced ejection fraction, correlates with better survival rates.
Heart Failure Crisis: Rising Mortality, Racial Disparities, and Systemic Challenges in the United States
The HF Stats 2024: Heart Failure Epidemiology and Outcomes Statistics reveals alarming trends in heart failure (HF) in the United States. Younger adults (ages 35-64) are increasingly affected, with rising mortality rates that surpass those of older adults. In 2021, HF-related deaths reached 425,147, accounting for 45% of cardiovascular deaths, with a notable surge during the pandemic.
Podcast: A Heart Transplant Recipient’s Journey
Each month, the Heart Failure Society of America’s Heart Failure Beat features candid conversations with heart failure clinicians about daily challenges, breakthroughs in research, treatment, career development, and more. The podcast is designed for cardiologists, clinicians, and trainees, as well as anyone else interested in heart failure news from leading experts.
Review Highlights Significant Advances and Ongoing Challenges in Heart Failure Management
A recent review by British Medical Journal researchers highlights the evolving landscape of heart failure management. The researchers analyzed studies from major databases, focusing on randomized clinical trials and cohort studies published between January 2015 and July 2023, aiming to update clinical practices that were not included in recent major heart failure guidelines.
Study Finds EAT-Lancet Diet Reduces Heart Failure Risk in Long-Term Analysis
Researchers explored the impact of the EAT-Lancet diet, which emphasizes plant-based foods and limits sugar and animal products, on heart failure risk. In an analysis of more than 23,000 participants with a median follow-up of 25 years, the study found that higher adherence to the EAT-Lancet diet was associated with a decreased risk of developing heart failure.
A Remote Heart Failure Monitoring Tool: Data Presented
A biomarker-guided predictive care company, Bodyport, showed that its FDA-cleared, non-invasive technology for remote heart failure monitoring detected twice as many heart failure events when compared to current standard of care. Data were presented at the third annual Technology and Heart Failure Therapeutics conference in Boston. During the study, the congestion index correctly predicted 48 of 69 heart failure events (70%), demonstrating higher sensitivity (p<0.01) than the weight-scale standard of care.
